Ekso Bionics (NASDAQ:EKSO) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Ekso Bionics (NASDAQ:EKSO) in a research report report published on Monday morning. The brokerage issued a hold rating on the stock.

A number of other research analysts have also recently issued reports on EKSO. Lake Street Capital decreased their price objective on shares of Ekso Bionics from $2.50 to $2.00 and set a “buy” rating for the company in a report on Tuesday, October 29th. HC Wainwright lowered their price objective on shares of Ekso Bionics from $10.00 to $9.00 and set a “buy” rating for the company in a research report on Tuesday, October 29th.

Ekso Bionics Trading Down 15.7 %

Shares of NASDAQ EKSO opened at $0.70 on Monday. The company’s 50 day simple moving average is $0.71 and its 200 day simple moving average is $0.96. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.81 and a quick ratio of 2.14. Ekso Bionics has a fifty-two week low of $0.50 and a fifty-two week high of $3.03. The firm has a market capitalization of $15.40 million, a P/E ratio of -1.08 and a beta of 1.47.

Ekso Bionics (NASDAQ:EKSO) last posted its quarterly earnings results on Monday, October 28th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.02). The company had revenue of $4.13 million during the quarter, compared to the consensus estimate of $6.00 million. Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. During the same quarter in the prior year, the business earned ($0.24) earnings per share. On average, analysts predict that Ekso Bionics will post -0.48 EPS for the current year.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.